25 May 2013
Keywords: bonviva, injection, set, eu, approval, swiss, major
Article | 06 February 2006
Swiss major Roche and UK-based giant GlaxoSmithKline say that a new four-times a year intravenous injection of the osteoperosis medication
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 February 2006
24 May 2013
© 2013 thepharmaletter.com